Aptamers targeting protozoan parasites

Biomedical Applications of Aptamers

Volumn , Issue , 2013, Pages 73-88

  González, Víctor M ^a   Elena Martin M ^a   Moreno, Miguel ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CENTRO DE ASTROBIOLOGÍA CSIC INTA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892069714     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (64)

1. Ndao M. (2009) Diagnosis of parasitic diseases: old and new approaches. Interdiscip. Perspect. Infect. Dis. 2009:278246.
2. Goto H., Lindoso J.A. (2010) Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert. Rev. Anti Infect. Ther. 8(4):419-433.
3. Lescure F.X., et al. (2010) Chagas disease: changes in knowledge and management. Lancet Infect. Dis. 10(8):556-570.
4. Sadanand S. (2010) Malaria: an evaluation of the current state of research on pathogenesis and antimalarial drugs. Yale J. Biol. Med. 83(4):185-191.
5. MalERA Consultative Group on Diagnoses and Diagnostics. (2011) A research agenda for malaria eradication: diagnoses and diagnostics. PLoS Med. 8(1):e1000396.
6. Murray C.K., Bennett J.W. (2009) Rapid diagnosis of malaria. Interdiscip. Perspect. Infect. Dis. 2009:415953.
7. Ashley E.A., White N.J. (2005) Artemisinin-based combinations. Curr. Opinion Infect. Dis. 18(6):531-536.
8. Day N.P.J., et al. (1999) The prognostic and pathophysiologic role of pro-and antiinflammatory cytokines in severe malaria. J. Infect. Dis. 180(4):1288-1297.
9. White N.J. (1998) Preventing antimalarial drug resistance through combinations. Drug Resistance Updates. 1(1):3-9.
10. Santos D.O., et al. (2008) Leishmaniasis treatment-a challenge that remains: a review. Parasitol. Res. 103(1):1-10.
11. McKerrow J.H., et al. (2008) Development of protease inhibitors for protozoan infections. Curr. Opin. Infect. Dis. 21(6):668-672.
12. Tuerk C., Gold L. (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 249:505-510.
13. Ellington A.D., Szostak J.W. (1990) In vitro selection of RNA molecules that bind specific ligands. Nature. 346:818-22.
14. Stoltenburg R., Reinemann C., Strehlitz B. (2007) SELEX-a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol. Eng. 24(4):381-403.
15. Keefe A.D., Pai S., Ellington A. (2010) Aptamers as therapeutics. Nat. Rev. Drug Discov. 9(7):537-550.
16. Ferreira C.S., et al. (2009) Phototoxic aptamers selectively enter and kill epithelial cancer cells. Nucleic Acids Res. 37(3):866-876.
17. Gragoudas E.S., et al. (2004) Pegaptanib for neovascular age-related macular degeneration. New Engl. J. Med. 351(27):2805-2816.
18. Yang X., Li N., Gorenstein D.G. (2011) Strategies for the discovery of therapeutic aptamers. Expert Opin. Drug Discov. 6(1):75-87.
19. Murray H.W., et al. (2005) Advances in leishmaniasis. Lancet. 366:1561-1577.
20. Schwartz E., Hatz C., Blum J. (2006) New world cutaneous leishmaniasis in travellers. Lancet Infect. Dis. 6(6):342-349.
21. Galanti N., et al. (1998) Histone genes in trypanosomatids. Parasitol. Today. 14(2):64-70.
22. Requena J.M., Alonso C., Soto M. (2000) Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol. Today. 16(6):246-50.
23. Ramos E., Moreno M., Martin M.E., Soto M., Gonzalez V.M. (2010) In Vitro Selection of Leishmania infantum H3-Binding ssDNA aptamers. Oligonucleotides. 20(4):207-213.
24. Ramos E., Pineiro D., Soto M., Abanades D.R., Martin M.E., Salinas M., Gonzalez V.M. (2007) A DNA aptamer population specifically detects Leishmania infantum H2A antigen. Lab. Invest. 87(5):409-416.
25. Moreno M., Rincon E., Pineiro D., Fernandez G., Domingo A., Jimenez-Ruiz A., Salinas M., Gonzalez V.M. (2003) Selection of aptamers against KMP-11 using colloidal gold during the SELEX process. Biochem. Biophys. Res. Comm. 308(2):214-218.
26. Fuertes M.A., et al. (1999), Folding stability of the kinetoplastid membrane protein-11 (KMP-11) from Leishmania infantum. Eur. J. Biochem. 260(2):559-567.
27. Moreno M., Gonzalez V.M., Rincon E., Domingo A., Dominguez, E. (2011) Aptasensor based on the selective electrodeposition of protein-linked gold nanoparticles on screen-printed electrodes. Analyst. 136(9):1810-1815.
28. Guerra N., Vega-Sendino M., Perez-Morgado M.I., Ramos E., Soto M., Gonzalez V.M., Martin M.E. (2011) Identification and functional characterization of a poly(A)-binding protein from Leishmania infantum (LiPABP). FEBS Lett. 585(1):193-198.
29. Rubio M.A., et al. (2000) Selective importation of RNA into isolated mitochondria from Leishmania tarentolae. RNA. 6(7):988-1003.
30. Schneider A., Martin J., Agabian N. (1994) A nuclear encoded tRNA of Trypanosoma brucei is imported into mitochondria. Mol. Cell. Biol. 14(4):2317-2322.
31. Mahapatra S., Adhya S. (1996) Import of RNA into Leishmania mitochondria occurs through direct interaction with membrane-bound receptors. J. Biol. Chem. 271(34):20432-20437.
32. Bhattacharyya S.N., Chatterjee S., Adhya S. (2002) Mitochondrial RNA import in Leishmania tropica: Aptamers homologous to multiple tRNA domains that interact cooperatively or antagonistically at the inner membrane. Mol. Cell. Biol. 22(12):4372-4382.
33. Kolesnikova O., et al. (2010) Selection of RNA aptamers imported into yeast and human mitochondria. RNA. 16(5):926-941.
34. Collier R. (2010) WHO reports progress in malaria control. CMAJ. 182(2):E105-E106.
35. Moll K., et al. (2007) A Novel DBL-domain of the P. falciparum 332 molecule possibly involved in erythrocyte adhesion. PLoS One. 2(5):e477.
36. Triglia T., et al. (2000) Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species. Molec. Microbiol. 38(4):706-718.
37. Normark J., et al. (2007), PfEMP1-DBL1α amino acid motifs in severe disease states of Plasmodium falciparum malaria. Proc. Natl. Acad. Sc. USA. 104(40):15835-15840.
38. Ahuja S., et al. (2006) Induction of cross-reactive immune responses to NTS-DBL-1alpha]/x of PfEMP1 and in vivo protection on challenge with Plasmodium falciparum. Vaccine. 24(35-36):6140-6154.
39. Hoffman S.L., et al. (1997) Toward clinical trials of DNA vaccines against malaria. Immunol Cell Biol. 75(4):376-381.
40. Crompton P.D., Pierce S.K., Miller L.H. (2010) Advances and challenges in malaria vaccine development. J. Clin. Invest. 120(12):4168-4178.
41. Good M.F., Doolan D.L. (2010) Malaria vaccine design: immunological considerations. Immunity. 33(4):555-566.
42. Barfod A., Persson T., Lindh J. (2009) In vitro selection of RNA aptamers against a conserved region of the Plasmodium falciparum erythrocyte membrane protein 1. Parasitol. Res. 105(6):1557-1566.
43. Francis S.E., Sullivan D.J., Goldberg D.E. (1997) Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Ann. Rev. Microbiol. 51:97-123.
44. Niles J.C., DeRisi J.L., Marletta M.A. (2009) Inhibiting Plasmodium falciparum growth and heme detoxification pathway using heme-binding DNA aptamers. Proc. Natl. Acad. Sc. USA. 106(32):13266-13271.
45. Li Y., Geyer C.R., Sen D. (1996) Recognition of anionic porphyrins by DNA aptamers. Biochem. 35(21):6911-6922.
46. Okazawa A., et al. (2000) In vitro selection of hematoporphyrin binding DNA aptamers. Bioorg. Med. Chem. Lett. 10(23):2653-2656.
47. MacGregor P., Matthews K.R. (2010) New discoveries in the transmission biology of sleeping sickness parasites: Applying the basics. J. Mol. Med. (Berlin). 88(9):865-871.
48. Jacobs R.T., Nare B., Phillips M.A. (2011) State of the art in African trypanosome drug discovery. Curr. Top. Med. Chem. 11(10):1255-1274.
49. Burri C. (2010) Chemotherapy against human African trypanosomiasis: is there a road to success? Parasitol. 137(14):1987-1994.
50. Magez S. Radwanska M. (2009) African trypanosomiasis and antibodies: implications for vaccination, therapy and diagnosis. Future Microbiol. 4(8):1075-1087.
51. Homann M., Goringer H.U. (1999) Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res. 27(9):2006-2014.
52. Homann M., Goringer H.U. (2001) Uptake and intracellular transport of RNA aptamers in African trypanosomes suggest therapeutic "piggy-back" approach. Bioorg. Med. Chem. 9(10):2571-2580.
53. Adler A., Forster N., Homann M., Goringer H.U. (2008) Post-SELEX chemical optimization of a trypanosome-specific RNA aptamer. Comb. Chem. High Throughput Screen. 11(1):16-23.
54. Homann M., et al. (2006) Serum-stable RNA aptamers to an invariant surface domain of live African trypanosomes. Combin. Chem. High Throughput Screen. 9(7):491-499.
55. Lorger M., Engstler M., Homann M., Goringer H.U. (2003) Targeting the variable surface of African trypanosomes with variant surface glycoprotein-specific, serumstable RNA aptamers. Eukaryotic Cell. 2(1):84-94.
56. Marin-Neto J.A., et al. (2008) Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). American Heart J. 156(1):37-43.
57. Ulrich H., et al. (2002) In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J. Biol. Chem. 277(23):20756-20762.
58. Gonçalves M.F., et al. (1991) Trypanosoma cruzi: Shedding of surface antigens as membrane vesicles. Exp. Parasitol. 72(1):43-53.
59. Goringer H.U., Homann M., Lorger M. (2003) In vitro selection of high-affinity nucleic acid ligands to parasite target molecules. Int. J. Parasitol. 33(12):1309-1317.
60. Goringer H.U., et al. (2006) RNA aptamers as potential pharmaceuticals against infections with African trypanosomes. Handbook Exp. Pharmacol. 173:375-393.
61. Neryl A.A., Wrenger C., Ulrich H. (2009) Recognition of biomarkers and cell-specific molecular signatures: Aptamers as capture agents. J. Sep. Sci. 32(10):1523-1530.
62. Pecoul B., et al. (1999) Access to essential drugs in poor countries: A lost battle? JAMA. 281(4):361-367.
63. Ulrich H., Wrenger C. (2009) Disease-specific biomarker discovery by aptamers. Cytometry Part A. 75A(9):727-733.
64. Bhattacharyya S.N., Chatterjee S., Adhya S. (2002) Mitochondrial RNA import in Leishmania tropica: Aptamers homologous to multiple tRNA domains that interact cooperatively or antagonistically at the inner membrane. Mol. Cell. Biol. 22(12):4372-4382.